COVID-19: The question of genetic diversity and therapeutic intervention approaches.
Figueiredo DLA, Ximenez JPB, Seiva FRF, Panis C, Bezerra RDS, Ferrasa A, Cecchini AL, Medeiros AI, Almeida AMF, Ramão A, Boldt ABW, Moya CF, Chin CM, Paula D, Rech D, Gradia DF, Malheiros D, Venturini D, Tavares ER, Carraro E, Ribeiro EMSF, Pereira EM, Tuon FF, Follador FAC, Fernandes GSA, Volpato H, Cólus IMS, Oliveira JC, Rodrigues JHDS, Santos JLD, Visentainer JEL, Brandi JC, Serpeloni JM, Bonini JS, Oliveira KB, Fiorentin K, Lucio LC, Faccin-Galhardi LC, Ferreto LED, Lioni LMY, Consolaro MEL, Vicari MR, Arbex MA, Pileggi M, Watanabe MAE, Costa MAR, Giannini MJSM, Amarante MK, Khalil NM, Lima Neto QA, Herai RH, Guembarovski RL, Shinsato RN, Mainardes RM, Giuliatti S, Yamada-Ogatta SF, Gerber VKQ, Pavanelli WR, Silva WCD, Petzl-Erler ML, Valente V, Soares CP, Cavalli LR, Silva WA Jr.
Figueiredo DLA, et al. Among authors: serpeloni jm.
Genet Mol Biol. 2022 Apr 8;44(1 Suppl 1):e20200452. doi: 10.1590/1678-4685-GMB-2020-0452. eCollection 2021.
Genet Mol Biol. 2022.
PMID: 35421211
Free PMC article.